Vera Therapeutics finance chief accounting officer Young Joseph R exercised Options for 5,000 shares at $3.94 per share. The transaction left him with 80,754 shares and 33,589 derivative securities, while representing about 6.2% of his resulting shares and 13.0% of his prior derivative securities holding.

Key Highlights

  • Young Joseph R’s option exercise occurred on 11 September 2026 under transaction code M.
  • The transaction represented about 6.2% of his resulting share holding.
  • His derivative securities holding stood at 33,589 after the exercise, with the transaction representing about 13.0% of his prior holding.

Vera Therapeutics, Inc. (NASDAQ: VERA) finance chief accounting officer Young Joseph R exercised options for 5,000 shares at $3.94 per share.

Option Exercise Changes Insider Holdings

The transaction took place on 11 September 2026. Young Joseph R held 80,754 shares after completing the transaction. The exercise price was $3.94 per share. Young Joseph R serves as senior vice president of finance and chief accounting officer at Vera Therapeutics.

Transaction Size Relative to Holdings

The 5,000-share exercise represented about 6.2% of Young Joseph R’s resulting share holding. The same transaction accounted for about 13.0% of his prior derivative securities holding.